News
08-28-2012, 03:41 AM
Approximately 20% of all breast cancer patients have overexpression of HER2 (human epidermal growth factor receptor 2), resulting in a more aggressive phenotype, and a poor prognosis.
More... (http://www.news-medical.net/news/20120828/Herceptinc2ae-(trastuzumab)-delivery-methods-an-interview-with-Dr-Gustavo-Ismael.aspx)
More... (http://www.news-medical.net/news/20120828/Herceptinc2ae-(trastuzumab)-delivery-methods-an-interview-with-Dr-Gustavo-Ismael.aspx)